Abstract
QUESTION: A 34-year-old patient of mine is taking a 'statin' for hyperlipidemia. She is planning pregnancy and is worried about the safety of the drug. How should I advise her? ANSWER: Limited evidence from animal and human studies indicates that statins should not be taken during pregnancy. If a patient is inadvertently exposed during pregnancy, however, termination does not appear to be medically indicated.
Full Text
The Full Text of this article is available as a PDF (128.1 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Blumenthal R. S. Statins: effective antiatherosclerotic therapy. Am Heart J. 2000 Apr;139(4):577–583. doi: 10.1016/s0002-8703(00)90033-4. [DOI] [PubMed] [Google Scholar]
- Dostal L. A., Schardein J. L., Anderson J. A. Developmental toxicity of the HMG-CoA reductase inhibitor, atorvastatin, in rats and rabbits. Teratology. 1994 Dec;50(6):387–394. doi: 10.1002/tera.1420500604. [DOI] [PubMed] [Google Scholar]
- Downs J. R., Clearfield M., Weis S., Whitney E., Shapiro D. R., Beere P. A., Langendorfer A., Stein E. A., Kruyer W., Gotto A. M., Jr Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA. 1998 May 27;279(20):1615–1622. doi: 10.1001/jama.279.20.1615. [DOI] [PubMed] [Google Scholar]
- Henck J. W., Craft W. R., Black A., Colgin J., Anderson J. A. Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats. Toxicol Sci. 1998 Jan;41(1):88–99. doi: 10.1006/toxs.1997.2400. [DOI] [PubMed] [Google Scholar]
- Hrab R. V., Hartman H. A., Cox R. H., Jr Prevention of fluvastatin-induced toxicity, mortality, and cardiac myopathy in pregnant rats by mevalonic acid supplementation. Teratology. 1994 Jul;50(1):19–26. doi: 10.1002/tera.1420500104. [DOI] [PubMed] [Google Scholar]
- Manson J. M., Freyssinges C., Ducrocq M. B., Stephenson W. P. Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancy. Reprod Toxicol. 1996 Nov-Dec;10(6):439–446. doi: 10.1016/s0890-6238(96)00130-x. [DOI] [PubMed] [Google Scholar]
- Miller V. T. Dyslipoproteinemia in women. Special considerations. Endocrinol Metab Clin North Am. 1990 Jun;19(2):381–398. [PubMed] [Google Scholar]
- Minsker D. H., MacDonald J. S., Robertson R. T., Bokelman D. L. Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase. Teratology. 1983 Dec;28(3):449–456. doi: 10.1002/tera.1420280316. [DOI] [PubMed] [Google Scholar]
- Napoli C., D'Armiento F. P., Mancini F. P., Postiglione A., Witztum J. L., Palumbo G., Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997 Dec 1;100(11):2680–2690. doi: 10.1172/JCI119813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Napoli C., Witztum J. L., Calara F., de Nigris F., Palinski W. Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses. Circ Res. 2000 Nov 10;87(10):946–952. doi: 10.1161/01.res.87.10.946. [DOI] [PubMed] [Google Scholar]
- Palinski W., D'Armiento F. P., Witztum J. L., de Nigris F., Casanada F., Condorelli M., Silvestre M., Napoli C. Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits. Circ Res. 2001 Nov 23;89(11):991–996. doi: 10.1161/hh2301.099646. [DOI] [PubMed] [Google Scholar]
- Sacks F. M., Pfeffer M. A., Moye L. A., Rouleau J. L., Rutherford J. D., Cole T. G., Brown L., Warnica J. W., Arnold J. M., Wun C. C. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996 Oct 3;335(14):1001–1009. doi: 10.1056/NEJM199610033351401. [DOI] [PubMed] [Google Scholar]
- Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]